Paul F. Lizzul, Chief Medical Officer at ANAPTYSBIO, INC (ANAB), sold 1,500 shares at $38.67 ($58K) on 2024-09-23, disclosed to the SEC on 2024-09-24.
Scheduled sale ($58k) by Chief Medical Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| ANAB | SELL | 2026-01-06 | $183K | — | Filing → |
| ANAB | SELL | 2025-12-23 | $75K | — | Filing → |
| ANAB | SELL | 2024-09-17 | $173K | — | Filing → |